Protection by milk immunoglobulin concentrate against oral challenge with enterotoxigenic Escherichia coli.

Author: GuesryP, HilpertH, HoangY, LevineM M, LinkH, LosonskyG, TacketC O

Paper Details 
Original Abstract of the Article :
Enterotoxigenic Escherichia coli is a common cause of traveler's diarrhea. Prophylaxis against traveler's diarrhea has been associated with side effects from bismuth subsalicylate and the development of resistance to antimicrobial agents. We undertook a double-blind controlled trial in which a bovin...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1056/NEJM198805123181904

データ提供:米国国立医学図書館(NLM)

Milk Immunoglobulin Concentrate: A Potential Prophylaxis for Traveler's Diarrhea

Traveler's diarrhea, a common affliction for those venturing to new lands, can be a real nuisance, leaving you feeling less than adventurous. This study explores the potential of a bovine milk immunoglobulin concentrate as a prophylaxis against enterotoxigenic Escherichia coli (ETEC), a major cause of traveler's diarrhea. It's like discovering a hidden oasis with a refreshing and protective beverage that could keep you from succumbing to the desert's harshest challenges.

The researchers conducted a double-blind controlled trial, comparing the effects of the immunoglobulin concentrate to a control group. Volunteers were challenged with ETEC after receiving either the immunoglobulin concentrate or a control immunoglobulin concentrate. The results were striking: none of the volunteers receiving the immunoglobulin concentrate developed diarrhea, while 9 out of 10 controls did. These findings suggest that the milk immunoglobulin concentrate may be an effective way to prevent ETEC-induced traveler's diarrhea.

New Avenues for Traveler's Diarrhea Prevention

This study provides compelling evidence for the potential of milk immunoglobulin concentrate as a prophylactic agent against traveler's diarrhea. The findings could lead to the development of new and effective preventive measures, potentially reducing the incidence and severity of traveler's diarrhea.

Implications for Travel Health and Well-being

The study's findings have significant implications for the health of travelers. This potential prophylaxis could offer a safe and effective alternative to existing methods, making travel more enjoyable and worry-free. It's like having a protective shield against the desert's harsh conditions, allowing you to explore new horizons with greater peace of mind.

Dr.Camel's Conclusion

This study is like a beacon of hope in the vast desert of traveler's diarrhea, offering a potentially effective way to avoid this common travel ailment. It suggests that a simple solution, like a refreshing drink from a hidden oasis, could be the key to preventing a potentially disruptive experience. This research opens up exciting possibilities for the future of travel health.

Date :
  1. Date Completed 1988-05-27
  2. Date Revised 2007-11-15
Further Info :

Pubmed ID

3283555

DOI: Digital Object Identifier

10.1056/NEJM198805123181904

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.